Non-invasive Ventilators Market (Product: Systems, Consumables; Application: Chronic Obstructive Pulmonary Disease, Asthma, Respiratory Distress Syndrome, Pneumonia, and Others; End Use: Critical Care, NICU Care, Transport (Ambulances), and Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

The global non-invasive ventilators market was surpassed at USD 1.69 billion in 2021 and is expected to hit around USD 3 billion by 2030, growing at a CAGR of 6.58% from 2022 to 2030.

Rise in medical emergencies and the need to manage critical patients from the initial point of emergency to the hospital or other healthcare settings continues to prevail. As the healthcare scenario progresses, treatment flexibility for patients has gained spotlight. Healthcare professionals aim to improve treatment and care provided in critical care settings or any other setup requiring emergency life-support and treatment. The evolution of healthcare marks the development of high-performance devices that enable healthcare professionals to upturn critical treatment.

Transparency Market Research (TMR), in its recently published study on the non-invasive market, unravels the key aspects driving the industry. The report reviews the main indicators that have marked the development of non-invasive ventilation, while analyzing the growing acceptance of the therapeutic method that has majorly contributed to the development of respiratory medicine over the past 25 years. Technological advances, such as innovation in the field of positive airway pressure (PAP) systems, portability, and improvement in battery life of transport and portable ventilators, are other factors propelling the non-invasive ventilators market growth.

Scope of The Report

Non-invasive Ventilators Market: Unveiling the Progress Path

The history of non-invasive ventilation dates back to the 20th century. Non-invasive ventilation was first used for the treatment of patients with acute respiratory failure, in the 1940s. The long-term use of non-invasive ventilators began to spur towards ventilatory progress during the 1980s. This was attributed to the improved understanding of the sleep physiology and beneficial effects of Continuous Positive Airway Pressure (CPAP). However, it was not until 1987 that the world witnessed the development of so-called modern non-invasive ventilation. Over the past two decades, the use of non-invasive ventilators has witnessed substantial growth, as technology advances, and the field of healthcare progresses on a fast-paced trajectory.

Presently, a robust evidence base detailing the efficacy of non-invasive ventilation in aggravations of cardiogenic pulmonary edema, acute respiratory failure, and chronic obstructive pulmonary disease in immunocompromised patients, highlights its evolutionary path. Moreover, its contribution in other settings such as hypoxemic acute respiratory failure and the management of patients who disapprove the process of endotracheal intubation is increasing rapidly. The non-invasive ventilators market is expected to reach a valuation of ~ US$ 1.69 Bn in 2021, and is likely to grow at a CAGR of ~ 6. 58% through the forecast period.

Impact of Undercurrents on the Non-invasive Ventilators Industry

According to WHO, chronic respiratory disease affects nearly one billion individuals, globally, making it one of the leading causes of death. This disease is prevalent in numerous forms, including chronic obstructive pulmonary disease (COPD), chronic bronchitis, asthma, pulmonary hypertension, and occupational lung disease. COPD occurrence has been closely linked to the rising air pollution in rural areas, and the burden of the disease is likely to grow in urban areas on account of the increasing prevalence of tobacco smoking. The demand for therapeutic devices such as non-invasive ventilators is likely to rise due to an increase in the diagnostic rates of various respiratory diseases.

The healthcare industry has witnessed rapid transformation over the years. As healthcare is becoming decentralized, patient care has exhibited a paradigm shift towards homes. Consumers are placing reliance on homecare with the constant support of technologically-advanced wearables, which not only aid in medication administration but also monitor treatment progress. Decentralizing healthcare to local centers is likely to enhance efficiency and address resource scarcity.

Another aspect that is likely to shape the future of the non-invasive ventilators market is the trends of portability and miniaturization, remote patient monitoring, and connectivity. Portable variants could be of use for treating patients with conditions such as pneumonia or in the course of mass casualty events.

One of the most common reasons that could hamper the adoption of non-invasive ventilators is the lack of experience. A substantial number of physicians do not use the conventional mode of non-invasive ventilation support. Proper application of masks and minimized air leaks are among the most vital factors that aid in improving patient compliance and ensuring enhanced ventilation. A protocol-based use of non-invasive ventilators remains crucial, which has created the need for providing adequate training for operators.

Winning Essentials for Non-invasive Ventilators Market Competitors

Expand Product Portfolio through Alliances

Companies providing non-invasive ventilators are considering collaborations to expand their global presence. Partnerships with companies providing respiratory devices help competitors broaden their portfolio of respiratory systems. Collaborations that aim at integrating next-gen technologies, such as flow sensor technologies that monitor and maintain precise control of the flow in non-invasive ventilators, are witnessed on a large scale.

Strengthen Foothold in Developing Economies

Increasing incidences of chronic respiratory diseases, tax benefits provided by regional governments, and rising healthcare expenditure cited across developing economies are garnering competitors’ attention. Owing to this, providers of non-invasive ventilators aim at expanding their latest offerings and strengthening their distribution network across developing economies.

Develop Adaptive Non-invasive Ventilators

As technology advances, non-invasive ventilators are likely to be integrated by next-gen capabilities that enhance their functionality, thereby improving the way care is provided. Auto-adaptive technology is one such capability gaining significance with time. Leading competitors are capitalizing on this development. For instance, Philips Respironics V60 utilizes the auto-adaptive technology to offer therapy acceptance and patient synchrony.

Analysis of the Competitive Landscape of the Non-invasive Ventilators Market

In November 2018, Royal Philips a leading health technology provider, announced the CE mark approval gained by the Philips V60 Plus ventilator. This solution inflates on Philips’ non-invasive ventilation gold standard platform, and integrates both, high flow therapy and non-invasion ventilation in a single device setting.

In May 2019, Dräger, a global leader in the field of medical and safety technology, received funds of up to EUR 110 million from The European Investment Bank (EIB) for R&D projects related to medical technology targeting life-saving systems, including ventilators and anesthesia systems.

Koninklijke Philips N.V., followed by ResMed Inc., continue to remain the leading players in the non-invasive ventilators market. With ~ 53% of the global market share held by these companies in 2020, the non-invasive ventilators market is expected to remain consolidated in nature. While major focus is centered on expanding research capabilities, a number of competitors are seen adopting the new product development strategy to introduce improved non-invasive ventilator systems and consumables. Another focus area is the acquisition of regional players in order to expand presence in lucrative geographies.

Analysts’ Inference of the Non-invasive Ventilators Market

TMR analysts have a positive perspective of the market for non-invasive ventilators. Asia Pacific is considered to be a high-growth regional market for non-invasive ventilators.  Infrastructural development and improved healthcare policies promoting better care provision are likely to be responsible for this growth. Surge in government investments in healthcare infrastructure in countries such as India and China, and strategic alliances among players to penetrate developing markets are expected to offer lucrative opportunities. As a result of this, new market entrants can consider developing economies for geographical expansion. In terms of market segments, investments for developing non-invasive ventilator consumables are likely to create greater sales revenue. Furthermore, focus on providing non-invasive ventilators in homecare settings could be a highly profitable avenue for competitors.

• The non-invasive ventilators market for the historical period of 2018-2020 and forecast of 2021-2030, the rising demand for home care ventilator systems and consumables is expected to boost the global non-invasive market during the forecast period.
• In terms of revenue, the global non-invasive ventilators market is estimated to reach ~ US$ 1.69 Bn by the end of 2021, and is expected to expand at a CAGR of ~ 6.58%, in terms of value, during the forecast period

Rise in Prevalence of Chronic Obstructive Pulmonary Diseases: A Key Driver

• The prevalence of COPD, asthma, and pneumonia is high across the globe. Moreover, rise in the awareness and advancements in diagnostic tools are increasing the diagnostic rate of these diseases. This, in turn, is likely to propel the consumption of non-invasive systems, such as non-invasive PPV and high flow nasal cannula O2 delivery, to treat these conditions.
• According to the World Health Organization (WHO), globally, 5 million deaths were caused by COPD in 2005, and nearly 3.17 million succumbed to the disease in 2016. In 2002, around 65 million people around the world were affected by moderate-to-severe COPD. 251 million cases of COPD were reported in 2016. Increase in the number of tobacco smokers and rise in air pollution are likely to increase the number COPD patients.
• Initiatives by key players and patient associations to raise awareness about COPD is anticipated to increase the diagnosis rate of COPD. Moreover, high prevalence of the disorder across the globe and surge in the demand for COPD devices from emerging markets are likely to fuel the non-invasive ventilators

Increase in Demand for Homecare and Portable Non-Invasive Ventilators the Latest Trend

• The demand for homecare and portable non-invasive ventilators is likely to boost the market. Furthermore, the adoption of multifunctional non-invasive ventilator machines is on the rise in emerging markets, which is likely to further propel the non-invasive ventilators
• Technical advancements in non-invasive ventilators have augmented the accuracy and reliability of these systems for the diagnosis of respiratory diseases. Moreover, their extensive applications in diagnosing others diseases is likely to fuel the non-invasive ventilators market.
• Rise in the adoption of non-invasive ventilators in emerging markets, owing to lack of proper use of ventilators, drives the non-invasive ventilators market in emerging economies. Surge in the number of healthcare providers in emerging markets is likely to fuel the adoption of non-invasive ventilators during the forecast period.
• Moreover, the affordability of COPD therapeutic devices such as portable non-invasive systems is likely to drive the adoption of these systems. Additionally, key players operating in the non-invasive ventilators market are investing in raising awareness about COPD, thereby increasing diagnostic rates. These factors are anticipated to drive the global non-invasive ventilators market during the forecast period.
• Moreover, increase in the number of tobacco smokers and rise in air pollution are key factors fueling the number of COPD cases. WHO estimates that, COPD is likely to be the third-leading cause of death by the year 2030.

Low Adoption Rate of Expensive Non-Invasive Ventilators Restrains the Non-Invasive Ventilators Market

• Respiratory disease is a leading cause of death, globally. Respiratory devices are required as assistive tools for long-term hospital administration and speedy recovery. The cost associated with respiratory devices is a key factor hampering the accessibility of these devices for lower-middle and lower-income groups.
• Moreover, medical devices are technology-driven, and hence, the introduction of new technology in the non-invasive ventilators market increases the demand and cost of medical devices. Increase in cost hinders the usage of non-invasive ventilators.
• Therefore, the low rate of adoption of expensive non-invasive ventilators is anticipated to restrain the market during the forecast period

Key Players

• Teleflex Incorporated
• Vyaire Medical
• Dragerwerk AG & Co. KGaA
• GE Healthcare
• Medtronic plc.
• Koninklijke Philips N.V.
• Smiths Medical
• ResMed, Inc.
• O-Two Medical Technologies Inc.
• Dimar s.r.l. Intersurgical Ltd.
• HAROL S.r.l. 
• Vygon SA,
• Getinge AB
• Vapotherm, Inc.
• Fisher & Paykel Healthcare Limited.

Market Segmentation

• By Product
  • Systems
    
    • Non-invasive PPV
    • High Flow Nasal Cannula O2 Delivery
    • Other Non-invasive
  • Consumable
    
    • Masks
    • Humidifiers
    • PEEP Valves
    • Others (Tubes, Connectors, etc.)
• By Application
  
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Respiratory Distress Syndrome
  • Pneumonia
  • Others
• By End Use
  
  • Critical Care
  • NICU
  • Transport (Ambulances)
  • Homecare Settings
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa